Studies carried out on the relationship between the onset of depressive symptoms and glycemic control in DM2 have shown that patients undergoing insulin therapy are more prone to depression than those undergoing treatment only with oral formulations, this pattern being related to the greater complexity of the regimen and the need for multiple daily injections [99,100,101]. This evidence concerns the gene INS and depressive disorder.